Literature DB >> 8952522

Cardiotrophin-1 inhibits tumor necrosis factor production in the heart and serum of lipopolysaccharide-treated mice and in vitro in mouse blood cells.

F Benigni1, S Sacco, D Pennica, P Ghezzi.   

Abstract

Cardiotrophin-1 (CT-1) is a member of the gp130 family of cytokines that includes interleukin-6, interleukin-11, ciliary neurotrophic factor, leukemia inhibitory factor, and oncostatin M. As interleukin-6, leukemia inhibitory factor, and ciliary neurotrophic factor were previously reported to inhibit the production of tumor necrosis factor (TNF), we studied the effect of CT-1 on serum and heart TNF levels in mice treated with lipopolysaccharide (100 ng/mouse, iv). Co-treatment with CT-1 (5 micrograms/mouse intravenously) markedly inhibit TNF production both in serum and in the heart. The effect of CT-1 seems to be direct as it also inhibited TNF production when added to whole mouse blood cultured with lipopolysaccharide. Thus, CT-1 might play a protective role in some TNF-mediated diseases.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8952522      PMCID: PMC1865339     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  16 in total

1.  IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice.

Authors:  D Aderka; J M Le; J Vilcek
Journal:  J Immunol       Date:  1989-12-01       Impact factor: 5.422

2.  Leukemia inhibitory factor protects against experimental lethal Escherichia coli septic shock in mice.

Authors:  P M Waring; L J Waring; T Billington; D Metcalf
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

3.  A new hepatocyte stimulating factor: cardiotrophin-1 (CT-1).

Authors:  M Peters; E Roeb; D Pennica; K H Meyer zum Büschenfelde; S Rose-John
Journal:  FEBS Lett       Date:  1995-09-25       Impact factor: 4.124

4.  Ciliary neurotrophic factor inhibits brain and peripheral tumor necrosis factor production and, when coadministered with its soluble receptor, protects mice from lipopolysaccharide toxicity.

Authors:  F Benigni; P Villa; M T Demitri; S Sacco; J D Sipe; L Lagunowich; N Panayotatos; P Ghezzi
Journal:  Mol Med       Date:  1995-07       Impact factor: 6.354

5.  Intratracheal injection of LPS and cytokines. V. LPS induces expression of LIF and LIF inhibits acute inflammation.

Authors:  T R Ulich; M J Fann; P H Patterson; J H Williams; B Samal; J Del Castillo; S Yin; K Guo; D G Remick
Journal:  Am J Physiol       Date:  1994-10

6.  Cardiotrophin-1. Biological activities and binding to the leukemia inhibitory factor receptor/gp130 signaling complex.

Authors:  D Pennica; K J Shaw; T A Swanson; M W Moore; D L Shelton; K A Zioncheck; A Rosenthal; T Taga; N F Paoni; W I Wood
Journal:  J Biol Chem       Date:  1995-05-05       Impact factor: 5.157

7.  Cytokines in acute myocardial infarction: selective increase in circulating tumor necrosis factor, its soluble receptor, and interleukin-1 receptor antagonist.

Authors:  R Latini; M Bianchi; E Correale; C A Dinarello; G Fantuzzi; C Fresco; A P Maggioni; M Mengozzi; S Romano; L Shapiro
Journal:  J Cardiovasc Pharmacol       Date:  1994-01       Impact factor: 3.105

8.  Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy.

Authors:  D Pennica; K L King; K J Shaw; E Luis; J Rullamas; S M Luoh; W C Darbonne; D S Knutzon; R Yen; K R Chien
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-14       Impact factor: 11.205

9.  Differentiation factor/leukemia inhibitory factor protection against lethal endotoxemia in mice: synergistic effect with interleukin 1 and tumor necrosis factor.

Authors:  H R Alexander; G G Wong; G M Doherty; D J Venzon; D L Fraker; J A Norton
Journal:  J Exp Med       Date:  1992-04-01       Impact factor: 14.307

10.  Defective inflammatory response in interleukin 6-deficient mice.

Authors:  E Fattori; M Cappelletti; P Costa; C Sellitto; L Cantoni; M Carelli; R Faggioni; G Fantuzzi; P Ghezzi; V Poli
Journal:  J Exp Med       Date:  1994-10-01       Impact factor: 14.307

View more
  3 in total

Review 1.  Cardiotrophin-1 (CT-1): a novel hypertrophic and cardioprotective agent.

Authors:  D S Latchman
Journal:  Int J Exp Pathol       Date:  1999-08       Impact factor: 1.925

2.  Cardiotrophin-1 (CT-1) improves high fat diet-induced cognitive deficits in mice.

Authors:  Dongmei Wang; Ling Liu; Junqiang Yan; Wenlan Wu; Xiaoying Zhu; Yong Wang
Journal:  Neurochem Res       Date:  2015-02-12       Impact factor: 3.996

3.  Preventive Effect of Cardiotrophin-1 Administration before DSS-Induced Ulcerative Colitis in Mice.

Authors:  Ana I Sánchez-Garrido; Vanessa Prieto-Vicente; Víctor Blanco-Gozalo; Miguel Arévalo; Yaremi Quiros; Daniel López-Montañés; Francisco J López-Hernández; Antonio Rodríguez-Pérez; José M López-Novoa
Journal:  J Clin Med       Date:  2019-12-01       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.